TCT 399: STRIKE-PE 90-Day Interim Results: Safety, Performance, and Quality of Life Outcomes in Pulmonary Embolism Patients Treated With Computer-Aided Thrombectomy
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Boston Scientific Corporation; Abiomed; Shockwave
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Penumbra